Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01GNL
|
|||
Drug Name |
Pyrazolopyridine derivative 5
|
|||
Synonyms |
PMID27774822-Compound-Figure9Example1topleft
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
TAKEDA PHARMACEUTICAL COMPANY LIMITED
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | TYK2 tyrosine kinase (TYK2) | Target Info | Inhibitor | [1] |
Target's Patent Info | TYK2 tyrosine kinase (TYK2) | Target's Patent Info | [1] | |
KEGG Pathway | Osteoclast differentiation | |||
Jak-STAT signaling pathway | ||||
Toxoplasmosis | ||||
Hepatitis C | ||||
Measles | ||||
Influenza A | ||||
Herpes simplex infection | ||||
Epstein-Barr virus infection | ||||
Pathway Interaction Database | IL27-mediated signaling events | |||
Signaling events mediated by PTP1B | ||||
IL12-mediated signaling events | ||||
IL6-mediated signaling events | ||||
IL23-mediated signaling events | ||||
Reactome | Interleukin-6 signaling | |||
MAPK3 (ERK1) activation | ||||
MAPK1 (ERK2) activation | ||||
Interferon alpha/beta signaling | ||||
Regulation of IFNA signaling | ||||
WikiPathways | Interferon type I signaling pathways | |||
IL-4 Signaling Pathway | ||||
IL-6 signaling pathway | ||||
Oncostatin M Signaling Pathway | ||||
Interleukin-11 Signaling Pathway | ||||
Type III interferon signaling | ||||
Interferon alpha/beta signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2.Expert Opin Ther Pat. 2017 Feb;27(2):145-161. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.